Cytyc Looking To Expand Ductal Lavage Franchise With Help Of HRT Study
This article was originally published in The Gray Sheet
Executive Summary
Cytyc plans to leverage results from a high-profile hormone replacement therapy study of postmenopausal women at risk for breast cancer in marketing its FirstCyte ductal lavage technology to ob/gyns